GLOBALCHARGE LIMITED

Financial Health Score: B- (Convalescing)

Explanation: The patient has recently recovered from a severe financial illness that depleted its reserves between 2019 and 2022. While the company is no longer in critical condition—demonstrating a return to profitability and a strong cash pulse—its overall financial "muscle mass" (net assets) remains significantly below historical peaks. The current ratio is slightly constricted by high trade creditors, suggesting the business is relying on supplier credit to fund its working capital. The prognosis is positive, provided the company continues its rehabilitative cash generation.

1. Key Vital Signs

• Blood Pressure (Liquidity): Slightly Elevated but Stable. The current ratio sits at approximately 1.28 (£717,910 current assets / £561,067 current liabilities). This is within a healthy range, meaning the company can comfortably cover its short-term debts. However, the heavy reliance on trade creditors (£417,700) means the business is running on a degree of supplier credit, which requires careful management.
• Pulse (Cash Flow): Strong. The cash position has swollen to £585,061, up from £332,151 in 2022. This represents a robust heartbeat, ensuring the company has the liquidity to survive unexpected shocks.
• Weight (Net Assets): Underweight. Net assets stand at £164,333. While this is an improvement on the previous year (£123,724), it is a fraction of the £664,190 recorded in 2019. The business has lost significant financial weight over the last five years.
• Cholesterol (Long-term Debt): Clear. The company has completely cleared its long-term liabilities, dropping from £18,934 in 2023 to £0 in 2024. This is an excellent sign of a cleansed financial system.
• Metabolism (Profitability): Active. The Profit and Loss reserve grew from £77,511 to £118,120, an increase of £40,609. This confirms the business is generating retained profit and no longer burning through its reserves.

2. Symptoms Analysis

• Historical Trauma (2019-2022): The financial history reveals a severe hemorrhage of value. Between 2019 and 2022, net assets dropped from £664,190 to £157,407. This was likely caused by either significant trading losses or the extraction of capital via dividends during a period of lower profitability (possibly pandemic-related, given the IT service sector's volatility during that time).
• Trade Creditor Inflammation: Trade creditors make up roughly 74% of all current liabilities. While this is interest-free credit that aids cash flow, it represents a lingering inflammation. If suppliers demand stricter payment terms, the company’s cash pulse could weaken rapidly.
• Director Changes: The recent resignation of two officers (Bernadette Anne Lyons and Antony Donovan Redfern) in late 2025 suggests a period of transition. While Antony Donovan Redfern remains a Person with Significant Control (PSC), his resignation as a director may indicate a shift in operational involvement that warrants monitoring.

3. Diagnosis

Condition: Post-Illness Recovery with Residual Weakness

GLOBALCHARGE LIMITED is convalescing. The acute phase of its financial distress (likely peaking around 2022 when net assets and cash hit their lowest points) has passed. The patient is responding well to treatment: profitability has returned, long-term debts have been excised, and the cash position has been rebuilt to healthy levels.

However, the balance sheet bears the scars of previous years. The retained earnings (P&L reserve) are still relatively thin at £118,120, and the overall net asset position remains fragile compared to its 2016-2019 strength. The business is currently functioning effectively but lacks the deep financial reserves it once possessed, making it more vulnerable to a sudden loss of revenue.

4. Recommendations

1. Rehabilitation Diet (Rebuild Reserves): The primary focus should be on retaining profits to rebuild the P&L reserve. Avoid aggressive dividend extractions until net assets return to pre-2020 levels. This will restore the company's financial "muscle mass" and resilience.
2. Cardiovascular Exercise (Improve Working Capital Cycle): Work on reducing the reliance on trade creditors. While £417k in creditor balances helps cash flow, stretching suppliers too far can damage vital commercial relationships and lead to restricted credit terms. Aim to accelerate debtor collection (currently £132,849) to fund faster creditor payment.
3. Vaccination (Cash Buffer Maintenance): Maintain the current strong cash position (£585k) as a buffer against future sector-specific downturns. Do not let this cash sit idle; consider placing surplus cash in high-yield business savings accounts to generate interest income while keeping it accessible.
4. Monitoring (Director Transition): Ensure that the recent resignations of officers do not lead to a loss of strategic direction. With Simon Jonathan Coates now appearing as the sole active director on the board, it is vital that governance and operational capacity are maintained without overburdening key personnel.